The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
The Impact of the Syncytium-Inducing Phenotype of Human Immunodeficiency Virus on Disease Progression
Abstract
Many patients infected with human immunodeficiency virus (HIV) yield syncytium-inducing (SI) virus isolates that are cytopathic in cell culture. The presence of SI virus was assessed in 325 persons entering 11 antiretroviral therapy trials and correlated with both CD4 cell declines and clinical end points. Adjusted mean rates of CD4 cell count decline were 40 and 102 cells/year in the non-SI (NSI) and SI groups, respectively (P < .0001). Rates of decline in 16 persons converting from NSI to SI virus averaged 31 cells/year before conversion and 142 cells/year afterward (P = .04). In a nested case-control analysis, persons who experienced surrogate marker end points or opportunistic infections were 2.3-3.5 times more likely to have SI virus than were controls (P = .01-.04) but who died were similar to controls with respect to virus phenotype (P = .70). Presence of the SI phenotype of HIV is a strong predictor of decline in CD4 cell count and progression of disease; however, controlling for the CD4 cell count, the SI phenotype did not increase the immediate risk of death.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymerase
Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B., & Erlich, H. A. (1988) · Science · doi:10.1126/science.2448875 · Cited by 17,719
Viral Infections of Humans. Epidemiology and Control.
(1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-98-2-273_2 · Cited by 749
Ashley, R. L., Militoni, J., Lee, F., Nahmias, A., & Corey, L. (1988) · Journal of Clinical Microbiology · doi:10.1128/jcm.26.4.662-667.1988 · Cited by 541
High Rate of HTLV-II Infection in Seropositive IV Drug Abusers in New Orleans
Lee, H., Swanson, P., Shorty, V. S., Zack, J. A., Rosenblatt, J. D., & Chen, I. S. Y. (1989) · Science · doi:10.1126/science.2655084 · Cited by 424
Gout, O., Baulac, M., Gessain, A., Semah, F., Saal, F., Périès, J., Cabrol, C., Foucault-Fretz, C., Laplane, D., Sigaux, F., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199002083220607 · Cited by 283
Seroprevalence and Epidemiological Correlates of HTLV-I Infection in U.S. Blood Donors
Williams, A. E., Fang, C. T., Slamon, D. J., Poiesz, B. J., Sandler, S. G., Darr, W. F., Shulman, G., McGowan, E. I., Douglas, D. K., Bowman, R. J., et al. (1988) · Science · doi:10.1126/science.2896386 · Cited by 265
Khabbaz, R. F., Onorato, I. M., Cannon, R. O., Hartley, T. M., Roberts, B., Hosein, B., & Kaplan, J. E. (1992) · New England Journal of Medicine · doi:10.1056/nejm199202063260604 · Cited by 192
Ehrlich, G. D., Glaser, J. B., LaVigne, K., Quan, D., Mildvan, D., Sninsky, J. J., Kwok, S., Papsidero, L. D., & Poiesz, B. (1989) · Blood · doi:10.1182/blood.v74.5.1658.1658 · Cited by 145
Infection with Human T-Cell Leukemia Virus Type I in Patients with Leukemia
Minamoto, G. Y., GOLD, J. W. M., Scheinberg, D. A., Hardy, W. D., Chein, N., Zuckerman, E. E., REICH, L. M., Dietz, K., Gee, T., Hoffer, J., et al. (1988) · New England Journal of Medicine · doi:10.1056/nejm198801283180405 · Cited by 93
Lee, H. H., Weiss, S. H., Brown, L. S., Mildvan, D., Shorty, V. J., Saravolatz, L. D., Chu, A. F., Ginzburg, H. M., Markowitz, N. P., Jarlais, D. C. D., et al. (1990) · The Journal of Infectious Diseases · doi:10.1093/infdis/162.2.347 · Cited by 92
Cited by
A case-control study of HIV seroconversion in health care workers after percutaneous exposure.
Cardo, D. M., Culver, D. H., Ciesielski, C. A., Srivastava, P. U., Marcus, R., Abiteboul, D., Heptonstall, J., Ippolito, G., Lot, F., McKibben, P. S., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711203372101 · Cited by 1,198
Giorgi, J. V., Hultin, L. E., McKeating, J. A., Johnson, T. D., Owens, B., Jacobson, L. P., Shih, R., Lewis, J., Wiley, D. J., Phair, J. P., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/314660 · Cited by 1,033
Shankarappa, R., Margolick, J. B., Gange, S. J., Rodrigo, A. G., Upchurch, D., Farzadegan, H., Gupta, P., Rinaldo, C. R., Learn, G. H., He, X., et al. (1999) · Journal of Virology · doi:10.1128/jvi.73.12.10489-10502.1999 · Cited by 926
AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor
Donzella, G. A., Schols, D., Lin, S. W., Esté, J. A., Nagashima, K. A., Maddon, P. J., Allaway, G. P., Sakmar, T. P., Henson, G., DeClercq, E., et al. (1998) · Nature Medicine · doi:10.1038/nm0198-072 · Cited by 760
A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity
Baba, M., Nishimura, O., Kanzaki, N., Okamoto, M., Sawada, H., Iizawa, Y., Shiraishi, M., Aramaki, Y., Okonogi, K., Ogawa, Y., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5698 · Cited by 751
Metadata
- Authors
- Richman, D. D., & Bozzette, S. A.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1994-05
- Volume
- 169
- Issue
- 5
- Pages
- 968-974
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2116789308
- Cited by
- 401
- References
- 11
- FWCI
- 8.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Impact of the Syncytium-Inducing Phenotype of Human Immunodeficiency Virus on Disease Progression. https://app.cochat.ai/papers/10.1093/infdis/169.5.968
- The paper
- Richman, D. D., & Bozzette, S. A. (1994). The Impact of the Syncytium-Inducing Phenotype of Human Immunodeficiency Virus on Disease Progression. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/169.5.968
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.